Biologic Therapies for Autoimmune and Inflammatory Disease States

• Monograph: Role of Biologics in Patients with Refractory Disease
• New Targets in Multiple Diseases
• Biologic Therapies and the Allied Health Professional
• Inflammatory Bowel Diseases and Biologic Agents
• Liver Disease
• Rheumatoid Arthritis, Juvenile Arthritis, Ankylosing Spondylitis
• Current Concepts in Psoriasis and Psoriatic Arthritis
• State of the Art: Biologic Toxicity Epidemiology, Clinical Spectrum, Diagnosis, and Prevention
• Advances in Mucosal Immunology
• Pros and Cons of the Quality Movement
• Biologic Therapeutic Classes and Agents: Shared Mechanisms of Action Across Disease States
• Immunologic Mechanisms in Bone Destruction: A New Therapeutic Target
• Not Enough Regulation in Innate Immunity
• B-Cell Selection and Repertoire and Autoimmunity
• Refractory Rheumatoid Arthritis
• Refractory Sjogren's Disease
• Refractory Ankylosing Spondylitis
• Idiopathic Inflammatory Myopathy Failing Standard Therapy
• Refractory Sarcoidosis
• Refractory Systemic Vasculitis
  

Clinical Decisions Cases

• Wegener's Granulomatosis

Managing the Problem Patient with Anti-TNF Inhibitors: Infectious, Malignant, Neurologic and Other Complex Issues Series

• Which Bacterial Infection Cause a Concern in Patients with TNF Inhibitors
• Hepatitis Issues
• The Pregnant Patient on a TNF Inhibitor
• Are TNF Inhibitors a Viable Option for Sarcoidosis?